THE EFFECT OF INTRAVENOUS ENALAPRILAT (MK-422) ADMINISTRATION IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION

被引：12

作者：

EVANS, RR

HENZLER, MA

WEBER, EM

DIPETTE, DJ

机构：

[1] UNIV TEXAS, OLD JOHN SEALY HOSP, MED BRANCH, GALVESTON, TX 77550 USA

[2] ALLEGHENY GEN HOSP, PITTSBURGH, PA 15212 USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 27卷 / 05期

关键词：

D O I：

10.1002/j.1552-4604.1987.tb03041.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：415 / 418

页数：4

共 14 条

[1] 3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J].

BIOLLAZ, J ;

BURNIER, M ;

TURINI, GA ;

BRUNNER, DB ;

PORCHET, M ;

GOMEZ, HJ ;

JONES, KH ;

FERBER, F ;

ABRAMS, WB ;

GAVRAS, H ;

BRUNNER, HR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :665-670

[2] HYPERTENSIVE CRISIS TREATED WITH ORALLY-ADMINISTERED CAPTOPRIL [J].

BIOLLAZ, J ;

WAEBER, B ;

BRUNNER, HR .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (02) :145-149

[3] CONVERTING ENZYME-INHIBITION WITH AN ORALLY ACTIVE COMPOUND IN HYPERTENSIVE MAN [J].

BRAVO, EL ;

TARAZI, RC .

HYPERTENSION, 1979, 1 (01) :39-46

[4] ENALAPRILAT, AN INTRAVENOUS ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, IN HYPERTENSIVE CRISES [J].

DIPETTE, DJ ;

FERRARO, JC ;

EVANS, RR ;

MARTIN, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) :199-204

[5] EFFECTS OF ENALAPRIL, A NEW CONVERTING ENZYME-INHIBITOR, IN HYPERTENSION [J].

FERGUSON, RK ;

VLASSES, PH ;

SWANSON, BN ;

MOJAVERIAN, P ;

HICHENS, M ;

IRVIN, JD ;

HUBER, PB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :48-53

[6] HEMODYNAMIC AND ANTIHYPERTENSIVE EFFECTS OF THE NEW ORAL ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR MK-421 (ENALAPRIL) [J].

FOUAD, FM ;

TARAZI, RC ;

BRAVO, EL ;

TEXTOR, SC .

HYPERTENSION, 1984, 6 (02) :167-174

[7]

GAVRAS H, 1981, LANCET, V2, P543

[8] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION [J].

GAVRAS, H ;

BIOLLAZ, J ;

WAEBER, B ;

BRUNNER, HR ;

GAVRAS, I ;

DAVIES, RO .

CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) :303-314

[9] ANTIHYPERTENSIVE EFFECT OF ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN [J].

GAVRAS, H ;

BRUNNER, HR ;

TURINI, GA ;

KERSHAW, GR ;

TIFFT, CP ;

CUTTELOD, S ;

GAVRAS, I ;

VUKOVICH, RA ;

MCKINSTRY, DN .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 298 (18) :991-995

[10] PHARMACOKINETICS OF REPEATED SINGLE ORAL DOSES OF ENALAPRIL MALEATE (MK-421) IN NORMAL VOLUNTEERS [J].

TILL, AE ;

GOMEZ, HJ ;

HICHENS, M ;

BOLOGNESE, JA ;

MCNABB, WR ;

BROOKS, BA ;

NOORMOHAMED, F ;

LANT, AF .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1984, 5 (03) :273-280

← 1 2 →